| Staurosporine | IC50 | 1.5 [1] |
| Indolactam V | Ki | 7.7 [1], 4110.0 [2] |
| Balanol | IC50 | 10.0 [1], 38.0 [2], 49.0 [3], 50.0 [4] |
| Balanol analog 5 | IC50 | 50.0 [1] |
| Balanol analog 4 | IC50 | 10.0 [1] |
| 8-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 262.0 [1], 262.3 [2], 10000.0 [3] |
| 2-[2,6-Dihydroxy-4-[3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 20.0 [1], 38.0 [2], 40.0 [3], 340.0 [4] |
| Bisindolylmaleimide i | IC50 | 6.0 [1], 6.6 [2], 12.0 [3] |
| Sotrastaurin | IC50 | 6.2 [1] |
| CID 25053598 | Ki | 21.1 [1], 31.0 [2], 42.8 [3] |
| 8-Octyl-benzolactam-V9 | Ki | 510.0 [1], 10000.0 [2] |
| (2S,5S)-8-Decyl-5-(hydroxymethyl)-1-methyl-2-propan-2-yl-2,4,5,6-tetrahydro-1,4-benzodiazocin-3-one | Ki | 13.1 [1], 187.0 [2], 8361.0 [3] |
| 2-[2,6-Dihydroxy-4-[2-[(4-hydroxybenzoyl)amino]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 50.0 [1] |
| Phorbol 12,13-dibutyrate | Ki | 1.35 [1], 14.9 [2] |
| Fasudil | IC50 | 3000.0 [1] |
| Enzastaurin | IC50 | 110.0 [1], 300.0 [2] |
| Ruboxistaurin | IC50 | 600.0 [1] |
| 1-(Tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 21.0 [1], 100000.0 [2] |
| PKCbeta Inhibitor | IC50 | 2800.0 [1], 2807.0 [2] |
| (E)-2-(2-(Hydroxymethyl)-4-(3-isobutyl-5-methylhexylidene)-5-oxo-tetrahydrofuran-2-yl)ethyl pivalate | Ki | 1.03 [1], 1.43 [2] |
| 8-Dec-1-ynyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,4,5,6-tetrahydro-2H-benzo[e][1,4]diazocin-3-one | Ki | 40.0 [1], 142.0 [2] |
| (1S,3R,5R,9R,13R)-9-(Hydroxymethyl)-3-[4-(3-hydroxyphenyl)butyl]-16,16-dimethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | Ki | 25.0 [1] |
| 3-(1H-Indol-3-yl)-4-[3-(4-methylpiperazin-1-yl)naphthalen-1-yl]pyrrole-2,5-dione | IC50 | 19.0 [1] |
| [(4Z)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl 5-methyl-3-(2-methylpropyl)hexanoate | Ki | 2.37 [1], 15.6 [2] |
| 5-Hydroxymethyl-2-isopropyl-1-undecyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 411.0 [1], 5360.0 [2] |
| (10S,13S)-13-(Hydroxymethyl)-9-methyl-10-propan-2-yl-3,9,12-triazatricyclo[6.6.1.04,15]pentadeca-1,4(15),5,7-tetraene-11-thione | Ki | 41.5 [1], 3860.0 [2] |
| 7-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 540.0 [1], 7880.0 [2] |
| 9-Decyl-5-hydroxymethyl-2-isopropyl-1-methyl-1,2,5,6-tetrahydro-benzo[e][1,4]oxazocin-3-one | Ki | 83.0 [1], 4830.0 [2] |
| [(4Z)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl (9E,12E)-octadeca-9,12-dienoate | Ki | 12.2 [1], 19.5 [2] |
| [(4E)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl (9E,12E)-octadeca-9,12-dienoate | Ki | 2.14 [1], 13.1 [2] |
| [(4Z)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl 8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octanoate | Ki | 9.8 [1], 30.7 [2] |
| [(4E)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl 8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octanoate | Ki | 5.5 [1], 19.84 [2] |
| [(4Z)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl 8-[3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl]octanoate | Ki | 16.3 [1], 63.0 [2] |
| [(4E)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl 8-[3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl]octanoate | Ki | 7.46 [1], 16.9 [2] |
| [(4Z)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl octadecanoate | Ki | 19.3 [1], 34.0 [2] |
| [(4E)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl octadecanoate | Ki | 11.4 [1], 47.0 [2] |
| [(4E)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl 5-methyl-3-(2-methylpropyl)hexanoate | Ki | 1.21 [1], 3.0 [2] |
| [(4Z)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl octadec-9-ynoate | Ki | 7.12 [1], 34.6 [2] |
| [(4E)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl octadec-9-ynoate | Ki | 4.79 [1], 9.1 [2] |
| [(4Z)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl octadeca-9,11-diynoate | Ki | 13.4 [1], 40.3 [2] |
| [(4E)-2-(Hydroxymethyl)-4-(3-methylbutylidene)-5-oxooxolan-2-yl]methyl octadeca-9,11-diynoate | Ki | 5.24 [1], 12.8 [2] |
| [(4Z)-2-(Hydroxymethyl)-4-[(9Z,12Z)-octadeca-9,12-dienylidene]-5-oxooxolan-2-yl]methyl 2,2-dimethylpropanoate | Ki | 5.06 [1], 9.6 [2] |
| [(4E)-2-(Hydroxymethyl)-4-[(9Z,12Z)-octadeca-9,12-dienylidene]-5-oxooxolan-2-yl]methyl 2,2-dimethylpropanoate | Ki | 4.1 [1], 5.2 [2] |
| [(4Z)-2-(Hydroxymethyl)-5-oxo-4-[8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octylidene]oxolan-2-yl]methyl 2,2-dimethylpropanoate | Ki | 15.2 [1], 58.8 [2] |
| [(4E)-2-(Hydroxymethyl)-5-oxo-4-[8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octylidene]oxolan-2-yl]methyl 2,2-dimethylpropanoate | Ki | 8.3 [1], 41.0 [2] |
| [(3E)-2-(Hydroxymethyl)-3-octadecylidene-5-oxooxolan-2-yl]methyl 2,2-dimethylpropanoate | Ki | 11.5 [1], 45.1 [2] |
| [(3Z)-2-(Hydroxymethyl)-3-octadecylidene-5-oxooxolan-2-yl]methyl 2,2-dimethylpropanoate | Ki | 5.9 [1], 34.2 [2] |
| 2-[2,6-Dihydroxy-4-[[2-[(4-hydroxybenzoyl)amino]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]oxycarbonyl]benzoyl]-3-hydroxybenzoic acid | IC50 | 27000.0 [1] |
| [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 3-[4-[2-(4-methylphenyl)ethynyl]phenoxy]propanoate | Ki | 78.7 [1], 153.0 [2] |
| [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 2-[4-[2-(4-methylphenyl)ethynyl]phenoxy]acetate | Ki | 147.0 [1], 268.0 [2] |
| [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 4-[4-[2-(4-methylphenyl)ethynyl]phenoxy]butanoate | Ki | 31.9 [1], 37.9 [2] |
| [2-(Hydroxymethyl)-5-oxo-4-propan-2-ylideneoxolan-2-yl]methyl 4-[2-(4-methylphenyl)ethynyl]benzoate | Ki | 8.3 [1], 10.0 [2] |
| [2-[(4-Hydroxyphenyl)methyl]cyclopentyl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonylbenzoyl)benzoate | IC50 | 4500.0 [1] |
| 2-[2,6-Dihydroxy-4-[4-[(4-hydroxybenzoyl)amino]pyrrolidin-3-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 10.0 [1] |
| 2-[2,6-Dihydroxy-4-[2-[(4-hydroxyphenyl)methyl]cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 500.0 [1] |
| 2-[2,6-Dihydroxy-4-[2-(4-hydroxyphenoxy)cyclopentyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 240.0 [1] |
| 2-[2,6-Dihydroxy-4-[4-[(4-hydroxyphenyl)methyl]pyrrolidin-3-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 20.0 [1], 1800.0 [2] |
| [4-[(4-Hydroxyphenyl)methyl]pyrrolidin-3-yl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonylbenzoyl)benzoate | IC50 | 4000.0 [1] |
| [(1R,2R,6S,10S,11R,13S,14R,15R)-13-Butanoyloxy-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] butanoate | Ki | 0.58 [1], 4.49 [2] |
| 2-[2,6-Dihydroxy-4-[(1R,2R)-2-[(4-hydroxybenzoyl)amino]cycloheptyl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 280.0 [1] |
| Balanol analog 3 | IC50 | 1800.0 [1] |
| 2-[3-(3-Piperazin-1-ylpropoxy)phenyl]-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)acetamide | IC50 | 1000.0 [1], 10000.0 [2] |
| 2-[2,6-Dihydroxy-4-[(3R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]-3-hydroxybenzoic acid | IC50 | 10.0 [1], 44.0 [2] |
| Phorbol 12-myristate 13-acetate | Ki | 0.45 [1] |
| Zidovudine | IC50 | 150000.0 [1] |
| Y-27632 Dihydrochloride | IC50 | 335.0 [1] |
| Betulinic acid | IC50 | 150000.0 [1] |
| Alvocidib | IC50 | 480.0 [1] |
| Chelerythrine chloride | IC50 | 24.0 [1] |
| Betulin | IC50 | 150000.0 [1] |
| Bisindolylmaleimide IV | IC50 | 7516.0 [1] |
| Purvalanol B | IC50 | 100000.0 [1] |
| Purvalanol A | IC50 | 100000.0 [1] |
| Aplysiatoxin | Ki | 1.3 [1] |
| Gsk-690693 | IC50 | 21.0 [1] |
| Debromoaplysiatoxin | Ki | 0.63 [1] |
| Platanic acid | IC50 | 150000.0 [1] |
| Rac-syn-Balanol | IC50 | 49.0 [1] |
| 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 100000.0 [1] |
| Acetobetulinic acid | IC50 | 150000.0 [1] |
| 7-Octylindolactam V | Ki | 1.0 [1] |
| (1S,3As,5aR,5bR,9S,11aR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-propan-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid | IC50 | 150000.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| (2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine | IC50 | 6100.0 [1] |
| (5-Hydroxy-1H-indol-2-yl)-(1H-indol-2-yl)methanone | IC50 | 30000.0 [1] |
| (2R)-2-[(2S)-4-[3-Chloro-5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol | Ki | 1.0 [1] |
| Betulinic acid 3-O-succinate | IC50 | 150000.0 [1] |
| Betulinic acid 3-O-crotonate | IC50 | 150000.0 [1] |
| 5-(3,4-Dimethoxyphenyl)-4-(1H-indol-5-ylamino)nicotinonitrile | IC50 | 2330.0 [1] |
| 4-(4-Methyl-1H-indol-5-ylamino)-5-(4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)nicotinonitrile | IC50 | 54.0 [1] |
| N'-(3-Pyridin-4-yl-2,6-naphthyridin-1-yl)ethane-1,2-diamine | IC50 | 5.0 [1] |
| Unii-09RR39UU4V | IC50 | 5600.0 [1] |
| Glycine, N,N-dimethyl-, 2-(1H-indol-2-ylcarbonyl)-1H-indol-5-yl ester | IC50 | 30000.0 [1] |
| Meridianin E | IC50 | 4000.0 [1] |
| Betulinic acid 3-O-benzoate | IC50 | 150000.0 [1] |
| 20-Ethyl-17,23-dioxa-4,14,20,26-tetrazahexacyclo[24.6.1.17,14.02,6.08,13.027,32]tetratriaconta-1(33),2(6),7(34),8,10,12,27,29,31-nonaene-3,5-dione | IC50 | 75.0 [1] |
| 6-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]-2-chloropyridin-3-yl}isoquinoline | IC50 | 5000.0 [1] |
| (2S,5S)-8-Dec-1-ynyl-5-(hydroxymethyl)-7-methoxy-1-methyl-2-propan-2-yl-2,4,5,6-tetrahydro-1,4-benzodiazocin-3-one | Ki | 121.3 [1] |
| 3-(1-Methyl-1H-indol-3-yl)-4-(1-piperidin-4-yl-1H-indol-3-yl)-pyrrole-2,5-dione | IC50 | 1000.0 [1] |
| 3-(1H-Indol-3-yl)-4-(2-piperazin-1-ylquinazolin-4-yl)pyrrole-2,5-dione | IC50 | 0.9 [1] |